#United States #New York #Securities Fraud #Rosen Law #Park Ha

Investors Seek to Lead Class Action Against Park Ha Biological Technology

In a significant development for investors of Park Ha Biological Technology Co., Ltd., the Rosen Law Firm has announced a class action lawsuit aimed at holding the company accountable for alleged securities fraud. This lawsuit covers shareholders who purchased Park Ha securities from December 27, 2024, to July 8, 2025—a period in which serious accusations regarding the company's misleading practices have emerged.

The Background

The Rosen Law Firm, recognized for its robust representation of investor rights, has declared that the lawsuit stems from the firm's commitment to combat fraud in the securities market. During the class period, Park Ha is accused of making materially false statements about its operations and potential, failing to disclose critical adverse facts that could mislead investors.

The firm is urging any affected investors to join the case, emphasizing that participation could mean potential compensation without upfront fees thanks to a contingency fee arrangement. This structure alleviates the financial burden of legal costs on shareholders who might have been affected by the alleged wrongful acts.

What's Next for Shareholders?

Those who wish to participate in the class action must act fast, as the deadline to move as a lead plaintiff is set for September 28, 2026. Interested investors can easily join the action through the Rosen Law Firm's dedicated website or by contacting attorney Phillip Kim directly. The potential lead plaintiff would play a crucial role in directing the ongoing litigation on behalf of other investors who experienced losses due to Park Ha's alleged fraudulent practices.

Details of the Allegations

According to the complaints filed, the lawsuit outlines several aspects of fraud purportedly executed by Park Ha. These include:

1. Fraudulent Stock Promotions: Defendants are accused of being involved in a deceptive stock promotion that utilized social media platforms to disseminate misinformation, which misled potential investors about the true value and prospects of Park Ha's stock.
2. Omitted Risk Disclosures: The company allegedly failed to mention any risks connected to the fraudulent rumors that artificially inflated its stock prices, thereby misleading investors about the stability of their investments.
3. Manipulative IPO Structuring: It's alleged that Park Ha intentionally designed its Initial Public Offering (IPO) with a minimal public float, enabling the manipulation of stock prices, which misrepresented its market position to investors.
4. Misrepresentation of Business Prospects: Due to these fraudulent activities, statements made by Park Ha regarding its business health and future prospects lacked a credible foundation and were misleading to shareholders.

The Rosen Law Firm's Commitment

The Rosen Law Firm has a remarkable history of defending investor interests and attaining significant settlements in securities class actions. The firm's commitment to fighting for the rights of shareholders is exemplified by their success in recovering billions for investors over the years. They invite individuals affected by Park Ha's practices to take advantage of their experienced legal counsel in the ongoing litigation.

Investors are encouraged to take action not only to potentially reclaim losses but also to uphold the integrity of the financial markets. Many previous clients are now measured against the outcomes achieved, showcasing the firm's successful track record.

To stay updated on this developing case, interested parties can follow the Rosen Law Firm on various social media platforms for timely information.

Conclusion

This class action lawsuit represents a pivotal moment for Park Ha Biological Technology investors, offering a path toward possible compensation for those adversely affected. As the deadline approaches for interested parties to take action, the urgency to join the class action is evident. Investors must act quickly to ensure their voices are heard in this critical legal battle.